The Difference in Wound Size Reduction Comparing Two Frequently Used Wound Dressings in Everyday Care
NCT ID: NCT03596112
Last Updated: 2020-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
77 participants
INTERVENTIONAL
2018-09-01
2020-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A randomized controlled trail with 90 participants in one wound care outpatient clinic is proposed.
Data will be analysed using SPSS version 23. Univariate and bivariate analysis will be conducted according to the data level and distribution.
This research project is designed to compare two wound dressings in everyday care. Since the cost of leg ulcers to individuals, the economy, and society is high, the evaluation of wound care dressings that leads to a reduction of wound size and promote wound healing are important for the individuals affected, their families, society at large and the health care system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds
NCT03662997
A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Safety, and Performance of ConvaFoam™ Dressings in the Management of Indicated Chronic Wound Types.
NCT05632250
Efficacy of Paste Type Acellular Dermal Matrix(CG Paste) in Chronic Wound Healing
NCT04019639
Study of the Efficacy of Sharp Debridement for the Management of Chronic Wounds
NCT00990522
Investigation of a Novel Wound Gel to Improve Wound Healing in Chronic Wounds
NCT03686904
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Predominantly a condition of the elderly, chronic wounds are becoming more prevalent and more difficult to treat and are associated with high treatment costs. The care for such conditions has been an estimated 2% to 3% of all health expenditures in developed countries (Posnett et al., 2009). With a Swiss health budget of 80 billion Swiss francs in 2016, this would translate into an annual cost up to 2.4 billion Swiss francs (Swiss Federal Statistical Office, 2016a).
.The care of chronic wounds has become its own specialty. The therapeutic approach to the management of CW is a multifaceted approach targeting the management of risk factors associated with healing rate and recurrence. Evidence showed the healing rate within a chronic wound is reported to be between 0.1 cm2 and 1cm2 per week independent of the wound-type (Hussain, 2015). The healing rate is mostly associated of the management of bacteria that is amongst other things manifested in wound odour and the used wound dressing and its absorption of wound exudate(Probst, 2015).
Wound odour is not attributed to any one particular source but is thought to be caused by a combination of bacteria including aerobic and anaerobic species, necrotic tissue, poorly vascularized tissue and light levels of exudate (Gethin, Grocott, Probst, \& Clarke, 2014). Malodour due to wounds can have a profoundly negative impact on the quality of life of the patient and of their carers causing feelings of guilt repulsion and leading to social isolation and depression (Gethin et al., 2014).
Wound exudate is a normal part of the wound healing process in any kind of wound. In general, the quantity of exudate produced decreases as the wound heals and progresses towards wound closure (Probst \& Huljev, 2013). Exudate is particularly noticeable during the inflammatory and proliferative phases of healing because it provides nutrients as an energy source for metabolizing cells and plays a role in regulating the moisture level in the local wound environment (Coleridge-Smith, Lok, \& Ramelet, 2005). This is the case in all chronic wounds. Managing a wound with a high level of exudate is one of the most commonly cited clinical problems not only in LU but also in DU or pressure ulcers (Chamanga, 2015; Probst, 2015; Tickle, 2015). High levels of exudate are challenging in terms of the selection of wound dressing products capable of handling the fluid levels and also the prevention of damage to the surrounding healthy skin (Tickle, 2015). Leakage of exudate through the dressing not only increases the risk of maceration or/ and cross-infection, it may also be distressing for the patient because of soiling of clothing and bedding and possible malodor (Probst, Arber, \& Faithfull, 2013b).Due to unabsorbed heavy exudate, healing is delayed and surrounding skin can be badly damaged due to maceration and excoriation (Chamanga, 2015). Additionally, the psychological effects of coping with a chronic wound on a day to day basis should not be underestimated (Probst, Arber, \& Faithfull, 2013a). For health services, the management of excess exudate presents considerable costs in terms of health professionals' time spent on more frequent visits to change dressings and costs for dressings and associated preventive measures such as skin protection (Probst, 2015). Therefore, the use of effective advanced wound dressings that manage exudate are an important aspect of wound therapy. There are many advanced wound dressings on the market absorbing excessive amounts of exudate. Currently the standard approaches to managing exudate and the presence of high bacteria load are dressings with silver such as the use of hydrocellular foam dressing with silver (non-adhesive or adhesive) or absorbent dressings. However, there is no evidence demonstrating the difference of wound size applying a sterile polyacrylate wound pad with activated carbon cloth treatment in comparison to a standard non -adhesive hydrocellular foam dressing with silver treatment.
This research project is designed to compare two wound dressings in everyday care. Through this comparison the effective amount of wound exudate in the population of LU and DU can be measured. Since the cost of leg ulcers to individuals, the economy, and society is high, the evaluation of wound care dressings that leads to a reduction of wound size and promote wound healing are important for the individuals affected, for society at large and the health care system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
polyacrylate wound pad
Use of cellulose and distinct layers of sodium-polyacrylate pad for wound care; frequency: twice a week
application of a polyacrylate wound pad
A sterile polyacrylate wound pad with activated carbon cloth treatment will be applied to chronic wounds in an outpatient clinic from a specialist nurse
hydrocellular foam pad
Use of standard foam pad for wound care; frequency: twice a week
Hydrocellular foam
Active Comparator: hydrocellular foam pad serile hydrocellular standard foam pad will be applied to chronic wounds in an outpatient clinic from a specialist nurse
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
application of a polyacrylate wound pad
A sterile polyacrylate wound pad with activated carbon cloth treatment will be applied to chronic wounds in an outpatient clinic from a specialist nurse
Hydrocellular foam
Active Comparator: hydrocellular foam pad serile hydrocellular standard foam pad will be applied to chronic wounds in an outpatient clinic from a specialist nurse
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Light to heavy exudating wounds
* Age over 18 years
* Proficiency in the French language
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
School of Health Sciences Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sebastian Probst
Prof Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sebastian E Probst, Prof Dr
Role: PRINCIPAL_INVESTIGATOR
University of Applied Sciences and Arts Western Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cité Génération Maison de santé
Onex, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Wound size reduction
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.